I am a
Home I AM A Search Login

Papers of the Week

2020 Apr 18

Ann Palliat Med

The efficacy of different doses of ulinastatin in the treatment of severe acute pancreatitis.


Severe acute pancreatitis (SAP) is a severe form of inflammatory disease with a high mortality rate. Ulinastatin, a urinary trypsin inhibitor, has anti-inflammatory properties and may be beneficial to critically ill patients with SAP. Nevertheless, there is currently insufficient evidence to conclude whether there is a dose-effect relationship between ulinastatin and SAP treatment outcomes. The present study examined the efficacy of ulinastatin at different doses in the treatment of SAP.